Swiss Toxicological Information Centre, Associated Institute of the University of Zürich , Zürich , Switzerland.
Clin Toxicol (Phila). 2014 Jul;52(6):629-34. doi: 10.3109/15563650.2014.918627. Epub 2014 May 20.
Seizures during intoxications with pharmaceuticals are a well-known complication. However, only a few studies report on drugs commonly involved and calculate the seizure potential of these drugs.
To identify the pharmaceutical drugs most commonly associated with seizures after single-agent overdose, the seizure potential of these pharmaceuticals, the age-distribution of the cases with seizures and the ingested doses.
A retrospective review of acute single-agent exposures to pharmaceuticals reported to the Swiss Toxicological Information Centre (STIC) between January 1997 and December 2010 was conducted. Exposures which resulted in at least one seizure were identified. The seizure potential of a pharmaceutical was calculated by dividing the number of cases with seizures by the number of all cases recorded with that pharmaceutical. Data were analyzed using descriptive statistics.
We identified 15,441 single-agent exposures. Seizures occurred in 313 cases. The most prevalent pharmaceuticals were mefenamic acid (51 of the 313 cases), citalopram (34), trimipramine (27), venlafaxine (23), tramadol (15), diphenhydramine (14), amitriptyline (12), carbamazepine (11), maprotiline (10), and quetiapine (10). Antidepressants were involved in 136 cases. Drugs with a high seizure potential were bupropion (31.6%, seizures in 6 of 19 cases, 95% CI: 15.4-50.0%), maprotiline (17.5%, 10/57, 95% CI: 9.8-29.4%), venlafaxine (13.7%, 23/168, 95% CI: 9.3-19.7%), citalopram (13.1%, 34/259, 95% CI: 9.5-17.8%), and mefenamic acid (10.9%, 51/470, 95% CI: 8.4-14.0%). In adolescents (15-19y/o) 23.9% (95% CI: 17.6-31.7%) of the cases involving mefenamic acid resulted in seizures, but only 5.7% (95% CI: 3.3-9.7%) in adults (≥ 20y/o; p < 0.001). For citalopram these numbers were 22.0% (95% CI: 12.8-35.2%) and 10.9% (95% CI: 7.1-16.4%), respectively (p = 0.058). The probability of seizures with mefenamic acid, citalopram, trimipramine, and venlafaxine increased as the ingested dose increased.
Antidepressants were frequently associated with seizures in overdose, but other pharmaceuticals, as mefenamic acid, were also associated with seizures in a considerable number of cases. Bupropion was the pharmaceutical with the highest seizure potential even if overdose with bupropion was uncommon in our sample. Adolescents might be more susceptible to seizures after mefenamic acid overdose than adults. "Part of this work is already published as a conference abstract for the XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 27-30 May 2014, Brussels, Belgium." Abstract 8, Clin Toxicol 2014;52(4):298.
药物中毒时发生癫痫是一种众所周知的并发症。然而,只有少数研究报告了常见的药物,并计算了这些药物的癫痫发作潜力。
确定在单一药物过量中毒后最常与癫痫发作相关的药物,这些药物的癫痫发作潜力,癫痫发作病例的年龄分布以及摄入剂量。
对 1997 年 1 月至 2010 年 12 月间瑞士毒理学信息中心(STIC)报告的急性单一药物暴露进行回顾性分析。确定至少有一次癫痫发作的暴露。通过将癫痫发作的病例数除以记录有该药物的所有病例数来计算药物的癫痫发作潜力。使用描述性统计数据进行数据分析。
我们确定了 15441 例单一药物暴露。313 例出现癫痫发作。最常见的药物是甲芬那酸(313 例中的 51 例)、西酞普兰(34 例)、曲米帕明(27 例)、文拉法辛(23 例)、曲马多(15 例)、苯海拉明(14 例)、阿米替林(12 例)、卡马西平(11 例)、马普替林(10 例)和喹硫平(10 例)。抗抑郁药涉及 136 例。癫痫发作潜在较高的药物为安非他酮(31.6%,19 例中的 6 例,95%CI:15.4-50.0%)、马普替林(17.5%,57 例中的 10 例,95%CI:9.8-29.4%)、文拉法辛(13.7%,168 例中的 23 例,95%CI:9.3-19.7%)、西酞普兰(13.1%,259 例中的 34 例,95%CI:9.5-17.8%)和甲芬那酸(10.9%,470 例中的 51 例,95%CI:8.4-14.0%)。在青少年(15-19 岁)中,涉及甲芬那酸的病例中 23.9%(95%CI:17.6-31.7%)发生癫痫发作,但在成年人(≥20 岁)中仅为 5.7%(95%CI:3.3-9.7%)(p < 0.001)。对于西酞普兰,这些数字分别为 22.0%(95%CI:12.8-35.2%)和 10.9%(95%CI:7.1-16.4%)(p = 0.058)。随着摄入剂量的增加,甲芬那酸、西酞普兰、曲米帕明和文拉法辛发生癫痫的概率增加。
抗抑郁药在药物过量中毒时与癫痫发作密切相关,但其他药物,如甲芬那酸,也与相当数量的病例发生癫痫发作有关。即使在我们的样本中安非他酮过量并不常见,安非他酮仍是癫痫发作潜在风险最高的药物。青少年在甲芬那酸过量后可能比成年人更容易发生癫痫发作。“这项工作的一部分已经作为欧洲中毒中心和临床毒理学协会(EAPCCT)第 XXXIV 届国际大会的会议摘要发表,2014 年 5 月 27 日至 30 日,比利时布鲁塞尔。”摘要 8,临床毒理学 2014;52(4):298。